Haruko Takeda, Senior Scientist
ULiège
Development of rapid and reliable alternative diagnostics for wide-scale COVID-19 testing. " Wide-scale implementation of rapid, reliable, low-cost diagnostic tests would help epidemic containment and mitigation strategies. The current gold standard in COVID-19 diagnostics employs quantitative reverse transcription (qRT) PCR which through cyclic reactions at different temperatures detects segments of the SARS-CoV-2 genome from RNA extracts from nasopharyngeal swabs. Though reliable, this procedure requires special sampling devices, purification of RNA, qualified personnel, sophisticated equipment, and a six hour turnaround time to result. By leveraging on university expert capacities such as molecular biology and protein science, our team has performed a series of controlled experiments to assess the specificity and sensitivity of loop- mediated isothermal amplification (LAMP)- and recombinase polymerase amplification (RPA)-based tests in comparison with the qRT-PCR procedure...